Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Scientific reports, 12, Article 6243, S. 6243-1-6243-5
- Event
-
Veröffentlichung
- (where)
-
Bochum
- (who)
-
Ruhr-Universität Bochum
- (when)
-
2022
- Creator
-
Bertram, Sebastian Johannes
Blazquez-Navarro, Arturo
Seidel, Maximilian
Hölzer, Bodo
Seibert, Felix Sebastian
Doevelaar, Adrian
Rohn, Benjamin Johannes
Zgoura, Panagiota
Witte‑Lack, Alexandra
Skrzypczyk, Sarah
Scholten, David
Kisters, Klaus
Babel, Nina
Westhoff, Timm
- URN
-
urn:nbn:de:hbz:294-103239
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:46 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bertram, Sebastian Johannes
- Blazquez-Navarro, Arturo
- Seidel, Maximilian
- Hölzer, Bodo
- Seibert, Felix Sebastian
- Doevelaar, Adrian
- Rohn, Benjamin Johannes
- Zgoura, Panagiota
- Witte‑Lack, Alexandra
- Skrzypczyk, Sarah
- Scholten, David
- Kisters, Klaus
- Babel, Nina
- Westhoff, Timm
- Ruhr-Universität Bochum
Time of origin
- 2022
Other Objects (12)
SARS-CoV-2 immunity through vaccination and infection in healthy individuals and haemodialysis patients
Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients
Age-associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockade
SARS-CoV-2 vaccination willingness and predictors in patients with chronic inflammatory rheumatic diseases (CIRD) and without CIRD
Spike-specific T cell immunity following vaccination against the human coronaviruses SARS-CoV-2 and MERS-CoV
Humoral Immunity in Immunosuppressed IBD Patients after the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control Subjects
BNT162b2 booster vaccination elicits cross-reactive immunity against SARS-CoV-2 variants B.1.1.529 and B.1.617.2 in convalescents of all ages
Vaccination against SARS-CoV-2: a human enhancement story
IL-13 determines specific IgE responses and SARS-CoV-2 immunity after mild COVID-19 and novel mRNA vaccination
SARS-CoV-2 specific cellular and humoral immunity after bivalent BA.4/5 COVID-19 vaccination in previously infected and non-infected individuals
Emergence of SARS‐CoV‐2 spike protein at the vaccination site
Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination
SARS-CoV-2 immunity through vaccination and infection in healthy individuals and haemodialysis patients
Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients
Age-associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockade
SARS-CoV-2 vaccination willingness and predictors in patients with chronic inflammatory rheumatic diseases (CIRD) and without CIRD
Spike-specific T cell immunity following vaccination against the human coronaviruses SARS-CoV-2 and MERS-CoV
Humoral Immunity in Immunosuppressed IBD Patients after the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control Subjects
BNT162b2 booster vaccination elicits cross-reactive immunity against SARS-CoV-2 variants B.1.1.529 and B.1.617.2 in convalescents of all ages
Vaccination against SARS-CoV-2: a human enhancement story
IL-13 determines specific IgE responses and SARS-CoV-2 immunity after mild COVID-19 and novel mRNA vaccination
SARS-CoV-2 specific cellular and humoral immunity after bivalent BA.4/5 COVID-19 vaccination in previously infected and non-infected individuals
Emergence of SARS‐CoV‐2 spike protein at the vaccination site
Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination
SARS-CoV-2 immunity through vaccination and infection in healthy individuals and haemodialysis patients
Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients
Age-associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockade
SARS-CoV-2 vaccination willingness and predictors in patients with chronic inflammatory rheumatic diseases (CIRD) and without CIRD
Spike-specific T cell immunity following vaccination against the human coronaviruses SARS-CoV-2 and MERS-CoV
Humoral Immunity in Immunosuppressed IBD Patients after the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control Subjects
BNT162b2 booster vaccination elicits cross-reactive immunity against SARS-CoV-2 variants B.1.1.529 and B.1.617.2 in convalescents of all ages
Vaccination against SARS-CoV-2: a human enhancement story
IL-13 determines specific IgE responses and SARS-CoV-2 immunity after mild COVID-19 and novel mRNA vaccination
SARS-CoV-2 specific cellular and humoral immunity after bivalent BA.4/5 COVID-19 vaccination in previously infected and non-infected individuals
Emergence of SARS‐CoV‐2 spike protein at the vaccination site